EUVIMEDEUVIMED entdecken
Crossref

Targeting ER Acetylation to Rescue Proteotoxicity

Luigi Puglielli

International Journal of Biomedical Science · 2023

DOI: 10.59566/iabs.2023.p003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biomedical Science, 2023. Verfasst von Luigi Puglielli.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transient acetylation within the endoplasmic reticulum (ER) lumen has emerged as a novel mechanism that regulates proteostasis and dynamics of the secretory pathway. The ER acetylation machinery includes AT-1, a membrane transporter that imports acetyl-CoA from the cytosol into the ER lumen, and two acetyltrasferases, ATase1 and ATase2, which acetylate ER cargo and resident proteins. Loss-of-function mutations or gene duplication events that affect ER acetylation are linked to developmental delay and premature death (homozygous mutation), hereditary forms of peripheral neuropathy (homozygous mutation), and autism spectrum disorder with intellectual disability and progeria (gene duplication). Mouse models of dysfunctional ER acetylation mimic associated human phenotypes.

Zitieren

APA

Puglielli, L. (2023). Targeting ER Acetylation to Rescue Proteotoxicity. International Journal of Biomedical Science. https://doi.org/10.59566/iabs.2023.p003

Vancouver

Puglielli L. Targeting ER Acetylation to Rescue Proteotoxicity. International Journal of Biomedical Science. 2023. doi:10.59566/iabs.2023.p003

BibTeX
@article{Puglielli2023,
  author = {Puglielli, Luigi},
  title = {Targeting ER Acetylation to Rescue Proteotoxicity},
  journal = {International Journal of Biomedical Science},
  year = {2023},
  doi = {10.59566/iabs.2023.p003}
}
Kostenlos starten →